Tania Nayak Kamphaus, Director, Metabolic Disorders & Patient Engagement, Foundation for the National Institutes of Health
Tanya Nayak Kamphaus is the Director for Metabolic Disorders Tanya is the Director for Metabolic Disorders Institutes of Health, also referred to as FNIH.
Podcast
Overview
Get ready to be inspired as we dive into the world of health and innovation with a remarkable individual. Meet Tania Kamphaus, the Director for Metabolic Disorders and Patient Engagement at the prestigious Foundation for the National Institutes of Health (FNIH). With a passion for bridging the gap between research and action, Tania is on a mission to transform the landscape of healthcare. Join us as we unravel her journey and discover the power of partnerships and patient involvement in combating metabolic diseases. Prepare to be enlightened and motivated by her remarkable insights and accomplishments.
00:36- About Tania Nayak Kamphaus
- Tanya Nayak Kamphaus is the Director for Metabolic Disorders Tanya is the Director for Metabolic Disorders Institutes of Health, also referred to as FNIH.
03:39- What is the meaning of metabolic disease?
- In the context of metabolic diseases, it is crucial to understand the impact on our internal organs such as the heart, liver, kidneys, and stomach.
- Sometimes, these organs may not function optimally due to various reasons, both specific to the organ and systemic in nature.
- Two prevalent culprits in this regard are diabetes and obesity, which can significantly affect organ function and contribute to the development of metabolic diseases.
15:21- Can you provide an overview and objective of the NIH Foundation’s initiative to engage patient voices in clinical study design?
- As a product developer, maximizing user benefit and profitability is crucial.
- This is especially true in the context of introducing new medicines or therapies.
- The uptake and success of these interventions greatly depend on the ability to gather feedback and understand the needs of the individuals who will be using them. However, incorporating patient voices into the development process can be complex due to the large and diverse stakeholder ecosystem involved.
- At our foundation, we are working towards a more meaningful integration of patient perspectives in the translational space.
- This involves actively seeking diverse patient voices, understanding their lived experiences, and using their feedback to inform study design and decision-making.
RESOURCES:
You can connect with Tania (Nayak) Kamphaus | LinkedIn
CONNECT WITH US:
Love to give us 5 stars? ⭐⭐⭐⭐⭐ If you do, we’d love a review from you. Help us reach more people to keep them in the know as we talk to leaders, high achievers, and thought leaders from diverse backgrounds and nationalities. Excellence can come from anywhere; stay in the know, and hear from emergent high achievers and gurus.
Stay updated with what’s shaping the world today through the latest The Brand Called You Podcast episode. Follow us on iTunes, Spotify, and Anchor.fm.
You can find us at:
Website: www.tbcy.in
Instagram: http://bit.ly/3HO7N06
Facebook:http://bit.ly/3YzJOaD
Twitter: http://bit.ly/3wMBOXK
LinkedIn: https://www.linkedin.com/company/tbcy/
YouTube: http://bit.ly/3jmBqfq
Chingari: https://chingari.io/tbcypodcast
Josh: http://bit.ly/3WWP0nB
Thanks for listening!
Profile
- Tanya Nayak Kamphaus is the Director for Metabolic Disorders Tanya is the Director for Metabolic Disorders Institutes of Health, also referred to as FNIH.
